Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients. Zinc has long been known to play a role in maintaining immunologic function. Hypozincemia, however, is common in patients with end-stage renal disease (ESRD) treated with continuous ambulatory peritoneal dialysis (CAPD). We previously demonstrated that zinc depletion limits the ability of animals to achieve maximum circulating calcitriol levels in response to the stress of calcium or phosphorus depletion. It was unclear, however, whether changes in the circulating levels of calcitriol in these settings was associated with a direct effect on renal 1-a hydroxylase activity, or whether the zinc dependence of the stimulated calcitriol response involved an integrated systemic response in intact animals. In addition it was unclear whether circulating zinc levels or zinc nutritional status modified calcitriol metabolism in humans. To better understand the role zinc plays in the immune response in patients with ESRD, we studied IL-i, calcitriol and tumor necrosis factor-a production by mononuclear cells from blood and peritoneal effluents of 22 patients with ESRD treated with CAPD. Macrophages from peritoneal effluents and peripheral blood mononuclear cells were isolated and pulsed with phytohemagglutinin in medium to which different concentrations of zinc chloride, copper chloride, and carbonyl cyanide p-(trifluoromethoxy)-phenyl-hydrazone (FCCP), an inhibitor of mitochondrial function were added. Supernatant interleukin-1, calcitriol, and tumor necrosis factor-a levels were subsequently measured. We demonstrated a zinc concentration dependent increase in stimulated IL-la and -13, and TNF-a release in both peripheral mononuclear cells and peritoneal macrophages from patients with ESRD treated with CAPD. The effect is zinc specific, as it is not reproduced by copper or chloride supplementation. A zinc concentration dependent increase in peritoneal macrophage calcitriol release was also noted. FCCP blocked the cellular production of IL-la, IL-113, and TNF-a, but had little effect on zinc-induced stimulated mononuclear cell supernatant calcitriol levels. The different shape of the zinc dose response curve, and the lack of correlation between paired IL-i and calcitriol supernatant levels suggests the effect of zinc on mononuclear cellular cytokine and calcitriol production is mediated through different pathways.
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Peritoneal host responses may be an important determinant of the incidence of peritonitis in patients with end-stage renal disease (ESRD) treated with continuous ambulatory peritoneal dialysis (CAPD). Attention has been focused on defects in intrinsic peritoneal macrophage and cellular responses, due to variations in ambient pH, glucose concentrations, osmolality of dialysates and dwell times, and the effect of coexistent conditions such as the uremic milieu [1] .
Immunologic defects in the environment of peritoneal macrophages which may affect antibacterial responses have been described [1] [2] [3] . Macrophages have the ability to 1-hydroxylate 25 OH D3 to produce 1,25 (OH)2 D3, or calcitriol [4, 5] , and calcitriol modulates lymphocyte interleukin (IL)-2 production, and monocytic IL-i RNA expression in CAPD patients [6] .
Hypozincemia is common in patients with ESRD [7] [8] [9] , and in patients treated with CAPD [9] . Redistribution of zinc from the extracellular to intracellular fluid, decreased zinc nutritional intake and intestinal absorption, and hypoalbuminemia may be factors determining the circulating level of zinc, rather than zinc loss in dialysis effluents [9, 10] . Nutritional zinc intake is probably the most important determinant of plasma zinc concentration in patients with renal disease [9] . Zinc supplementation in hypozincemic patients with ESRD has been shown to modify lymphocyte and neutrophil responses [11] . We previously demonstrated that zinc depletion limits the ability of animals to achieve maximum circulating calcitriol levels in response to the stress of calcium or phosphorus depletion [12, 131 . It was unclear, however, whether changes in the circulating levels of calcitriol in these settings was associated with a direct effect on renal i-a hydroxylase activity, or whether the zinc dependence of the stimulated calcitriol response involved an integrated systemic response in intact animals.
In preliminary studies, we assessed the effect of extracellular zinc concentration on IL-i and calcitriol release from peritoneal macrophages [14] . In order to better understand the role zinc plays in the immune response in patients with ESRD, we presently studied IL-i, calcitriol and tumor necrosis factor-a (TNF-a) production by mononuclear cells from blood and peritoneal effluents of patients with ESRD treated with CAPD, and assessed the role of mitochondrial function in their metabolism.
Methods

Patients
Received for publication April 21, 1995 and in revised form November 22, 1995 Accepted for publication November 27, 1995 © 1996 by the International Society of Nephrology A total of 22 patients with ESRD treated with CAPD participated in three separate studies after giving informed consent. All patients had been treated with CAPD for at least two months. No patient had clinical or laboratory evidence of peritonitis at the time of evaluation. All patients had simultaneous evaluation of serum urea and creatinine concentration. Overnight dwells from CAPD exchanges were used to isolate peritoneal macrophages (PM) for evaluation of cellular cytokine production. Five milliliters of whole blood were obtained in citrated glass tubes for isolation of peripheral blood mononuclear cells (PBM) from patients at the time of collection of peritoneal effluents. Nine CAPD patients had simultaneous determination of serum urea nitrogen (SUN), serum creatinine and plasma and peritoneal effluent zinc concentrations. Eight patients with essential hypertension, untreated with any medication, in the placebo arm of a drug study had plasma zinc determinations as controls. SUN and serum creatinine assays were performed in the clinical laboratory of the George Washington University Medical Center Ambulatory Care Center. Determination of plasma and peritoneal effluent zinc concentration was performed by atomic absorption spectrophotometry as previously described [10] . The study was approved by the George Washington University Committee on Human Research.
Cellular studies
Macrophages from peritoneal effluents were isolated after centrifugation and separation by density centrifugation on ficollhypaque [15] . Cells were washed in Eagles medium (zinc concentration = 0.3 mg/liter), counted and their viability checked by Trypan blue exclusion. Mononuclear phagocytic cells were separated by exposure to carbonyl iron, and subsequent separation in a magnetic field. PBM were isolated and evaluated as previously described [15] , simultaneously with collection of peritoneal effluents. Suspensions of cells were washed, and batches were adjusted to i05 cell/ml, before pulsing with 50 ig/ml phytohemagglutinin (PHA). Cells were incubated for 24 hours at 37°C, following which they were centrifuged, and the supernatants used in a stimulation assay, as previously described [15] . The cells were examined under three conditions. Media was supplemented with either no trace metal (zero), or zinc chloride at concentrations of 0.5, 1.0, or 2.0 mg/liter. When no trace metal was added, unstimulated as well as PHA-stimulated cellular cytokine production was determined. In two separate sets of studies only PHA-stimulated cellular cytokine production was assessed. In the final assessment, media was supplemented with no trace metal, zinc or copper chloride at concentrations of 0.5, 1.0, or 2.0 mg/liter. Copper chloride was employed as a control for both trace metal and chloride ions.
Cytokine determinations A bioassay for IL-i was employed, as previously described from our laboratory [15] in the first two phases of the study. In brief, 1 ml of each supernatant was serially diluted, and incubated with 1 x iO CRL 1445 IL-i dependent fibroblasts (ATCC, Rockville, MD, USA) in culture for 48 hours at 37°C. Target cells were harvested, counted, and 1 x i0 cells were pulsed in fresh media with tritiated thymidine for 24 hours at 37°C. The number of cells per culture was checked using a manual cytometer prior to harvesting, and the results reported as counts per minute (CPM) per culture readjusted to 1 x i05 cells. In addition, in the third phase of the study, IL-ia, IL-j3, and TNF-a were measured by a commercial ELISA (R and D Systems, Minneapolis MN, USA). These results are reported in pg/mi supernatant. The lower limit of detection for the ELISAs was 1 pg/ml. All undetectable levels were entered as 1 pg/mI for analysis. Measurements were made in triplicate for each sample in all interleukin and TNF-a assays.
Calcitriol assays
Calcitriol levels in supernatants were measured by adaptation of previously published techniques [16] . In brief, 1 ml of culture supernatant was extracted with acetonitrile and washed with a basic buffer, subjected to sequential silica and C18 mini-column chromotography, and the 1,25 (OH)2D3 fraction was purified further using high performance liquid chromatography (HPLC), as previously described [17] . The HPLC eluate containing the 1, 25 (OH)2D3 fraction was measured in triplicate in a radioreceptor assay, using a binding protein prepared from calf thymus cytosol, as previously described [12] [13] [14] 17] . The lower limit of detection of the assays utilized in these studies was ito 2 pg/mI. Intraassay and interassay coefficients of variation were 8 and 14%, respectively, for the assays utilized in this study.
Inhibition of mitochondrial function
Ten tM/liter carbonyl cyanide p-(trifluoromethoxy)phenyl-hydrazone (FCCP) (Sigma Co, St. Louis, MO, USA) added to the incubation medium, was used as an uncoupler of mitochondrial oxidative phosphorylation [18] .
Data analysis
Data were analyzed by analysis of variance (ANOVA) to compare mean levels of supernatant cytokines within groups at different supplemented levels of zinc or copper concentrations. Differences between mean levels between groups at particular concentrations of additional zinc or copper were assessed by ANOVA and confirmed with Fisher's PLSD test. Mean stimulated supernatant cytokine levels in PM and PBM cultures, and mean stimulated supernatant calcitriol levels in PM exposed and unexposed to FCCP at similar zinc concentrations were compared using paired t-tests. Mean stimulated supernatant zinc, copper and FCCP modified cytokine levels in PM and PBM cultures, both within groups at different supplemented zinc and chloride concentrations, and between the three groups at similarly supplemented zinc and chloride concentrations were compared using ANOVA, followed by confirmation with Fisher's PLSD tests. P < 0.05 was taken as the level of significance. All data are reported as mean SEM.
Results
Study 1
To determine whether extracellular zinc levels modulate mononuclear cell cytokine production, nine patients with ESRD treated with CAPD were studied. These subjects also had simultaneous determination of plasma and peritoneal fluid zinc concentration. Laboratory values of these patients are provided in Table 1 . The mean plasma zinc concentration in the nine CAPD patients was 2.4 0.1 mg/liter, less than 50% of, and significantly lower (P < 0.0001) than the mean value in the hypertensive controls, 5.8 0.4 mg/liter. Mean peritoneal fluid zinc concentration in the nine patients was 33 5 big/liter, roughly two orders of magnitude less than the mean plasma level in this group of patients. Plasma and peritoneal zinc concentrations, however, were correlated in the patients (r = 0.69, P < 0.05). There was no correlation between plasma creatinine and zinc concentrations in these patients. There was also no correlation between plasma or peritoneal zinc concentration with either unstimulated or PHA-stimulated macrophage IL-i levels at any concentration of added zinc chloride. The mean unstimulated PM IL-i release, with no additional zinc added, was 409 24 CPM/culture, and increased 607% after stimulation with PHA to 2892 321 CPM/culture (P < 0.0001). The stimulated PM IL-I release increased significantly at each additional increment of zinc concentration, compared with the unstimulated value, and between each additional increment of zinc concentration (P < 0.0001, ANOVA).
Study 2
Study 2 was designed to determine whether differences exist between PBM and PM IL-i production in response to changes in extracellular zinc levels, and whether extracellular zinc levels modulate mononuclear cell calcitriol production in patients treated with CAPD. In addition, the experiments were designed to determine whether zinc mediated mononuclear cell calcitriol production was dependent on mitochondrial function. Twelve CAPD patients, studied in one session, had simultaneous evaluation of both PBM and PM responses to graded increases in media zinc concentration. All twelve had mononuclear cell calcitriol production, as well as IL-i production evaluated. In this study, stimulated IL-i levels were employed as a control for level of mononuclear cell activation [19] . In simultaneous experiments, FCCP added to the incubation medium was used as an uncoupler of mitochondrial oxidative phosphorylation [18] .
Results of supernatant IL-i level studies in unstimulated and stimulated PBM cultures were similar to those assessed in PM cultures. Once again, there was a zinc dependent, monotonic increase in IL-i levels at each additional incremental level of added zinc concentration (Fig. 1) . Both PBM and PM IL-i levels at each different zinc concentration were different from all other determinations (P < 0.0001, ANOVA). Stimulated PBM IL-i levels were greater than PM IL-i levels at each zinc concentration studied (P = 0.0001; Fig. 1 ). There was no correlation between patients' plasma zinc concentration and stimulated cellular supernatant IL-i levels in any assessment.
Mean stimulated PM supernatant calcitriol concentration, without the addition of zinc was 225 4i pg/ml. The stimulated PM supernatant calcitriol concentration increased approximately 3.5-fold at 1.0 and 2.0 mg/liter zinc concentration, compared with the level when zinc was not added (P < 0.03, ANOVA; Fig. 2) . In contrast to the findings when IL-i was evaluated, in which a monotonically increasing level of IL-i release was seen with each incremental addition of zinc chloride in PM or PBM cultures, there was no difference between stimulated PM supernatant calcitriol levels when assessed at zinc concentrations of 1.0 and 2.0 mg/liter (Fig. 2) . Stimulated supernatant IL-i and calcitriol levels were not correlated, nor was there a correlation of patients' plasma zinc and stimulated cellular calcitriol supernatant levels in any assessment. The addition of FCCP to medium with different concentrations of supplemental zinc chloride did not diminish supernatant calcitriol levels, although it abolished the zinc-mediated increase in supernatant calcitriol levels (Fig. 3) . Supernatant calcitriol levels were higher in the baseline condition without added zinc or FCCP (623 120 vs. 207 35 pglml, P < 0.01). There was, however, no difference between mean supernatant calcitriol levels in cell cultures treated with and without FCCP, at added zinc concentrations of 0.5, 1.0, and 2.0 mg/ml (Fig. 3) .
Study 3
This study was designed to determine whether the zinc mediated effects were trace metal specific, and to assess the role of Mean supernatant calcitriol levels were greater in cultures with additional FCCP (circles), in the absence of added zinc chloride, but there was no change in calcitriol levels in the presence of additional zinc chloride (ANOVA). There was also no difference between supernatant calcitriol levels at any level of supplemental zinc in cells exposed and unexposed to FCCP.
chloride ion by using copper chloride as a trace metal control. In addition, the experiments were designed to determine whether zinc mediated cytokine production and release was dependent on mitochondrial function. Twenty-two patients had PM and PBM cell stimulated superriatant IL-la and -13, and TNF-a levels evaluated in media with different zinc and copper chloride concentrations. In simultaneous experiments, FCCP was used as an inhibitor of mitochondrial function. Mean PHA-stimulated PM supernatant IL-la concentration, with no additional zinc added, was 10.5 1.1 pg/mI. PM supernatant IL-la levels increased significantly at each additional increment of zinc concentration, compared with baseline and with each additional increment of zinc concentration (P < 0.0001, ANOVA; Fig. 4 ). Although baseline response was similar to that of the zinc treated cells, there was no effect of increasing the concentration of copper chloride on PHA stimulated PM supernatant IL-la level in the absence of supplemental zinc chloride (Fig. 4) . The addition of FCCP to PM treated with zinc resulted in the abolition of the zinc-induced increase in supernatant IL-la levels. Supernatant IL-I a levels in PM exposed to FCCP were all similar, but all lower than the mean P1-IA-stimulated PM supernatant IL-la concentration, with no additional zinc added (P < 0.000 1, ANOVA; Fig.  4 ). There was no difference between supernatant IL-la levels in PM exposed to zinc or copper at a concentration of 0.5 mg/liter; however, there were differences between all three groups at zinc or copper concentrations of 1 and 2 mg/liter. The interassay and intraassay coefficients of variation for this IL-la assay were 6.9 and 7.4%, respectively. Similar responses were noted regarding stimulated PM IL-113 (Fig. 5 ) and TNF-a (Fig. 6 ) supernatant concentration in cultured cells treated with zinc, copper, and zinc plus FCCP, except there were differences between all three groups at each different concentration of supplemental zinc or copper in these studies (P < 0.0001, ANOVA). The interassay and intraassay coefficients of variation for this IL-lp and TNF-a assay were
Added zinc or copper concentration, mg/liter the absence of FCCP (P = 0.0001, ANOVA). There was no effect of additional copper chloride on supernatant IL-la levels. The addition of FCCP markedly reduced supernatant IL-la levels (P = 0.0001, ANOVA). and without (circles) the addition of FCCP. Simultaneous experiments substituted addition of copper chloride rather than zinc chloride at 0.5, 1.0 and 2.0 mg/liter, as a control for the effect of both the trace metal and the chloride ion (squares), in the absence of FCCP. There was a monotonically increasing level of supernatant IL-ip at each level of added zinc, in the absence of FCCP (P = 0.0001, ANOVA). There was no effect of additional copper chloride on supernatant IL-1f3 levels. The addition of FCCP markedly reduced supernatant IL-1/3 levels (P = 0.0001, ANOVA).
8.2 and 8.8%, and 8.3 and 7.6%, respectively. A similar zincinduced increase of IL-la, IL-1/3, and TNF-a was noted in PBM (data not shown). Addition of copper chloride had no effect on PHA-stimulated PBM cytokine levels, but the zinc-induced increase in supernatant IL-la, IL-1f3, and TNF-a concentrations was completely abolished by the addition of FCCP to the medium. with renal disease. We, however, demonstrated a zinc concentration dependent increase in stimulated IL-la and -/3, and TNF-a release in both peripheral blood mononuclear cells and peritoneal macrophages from patients with ESRD treated with CAPD. The effect noted is zinc specific, as it is not reproduced by copper or chloride supplementation. There was, however, no correlation between patients' plasma and peritoneal zinc levels and cytokine biology in this in vitro study. This is not surprising since the cells were washed and placed in culture medium before supernatants were sampled. Such an effect on mononuclear cell biology is consistent with the well known effects of zinc as a cofactor for activation of various enzymes, and described roles of zinc in transcription and translation [26, 27] .
We were able to extend these findings to another monokine, calcitriol. We have shown a zinc concentration dependent increase in peritoneal macrophage calcitriol release. Clinically in humans, parathyroid hormone and phosphorus nutritional status are the most important determinants of renal 1-a hydroxylase activity and therefore of circulating calcitriol levels [4] . Other hormones and changes in extracellular ion levels may also modulate the response of calcitriol to physiological stressors [4] . A change in zinc nutritional status might conceivably alter such factors. Our data, however, are consistent with a direct effect of zinc to modulate extrarenal cellular 1-a hydroxylase activity. FCCP, an inhibitor of mitochondrial respiration, blocked the cellular production of IL-la, IL-1f3, and TNF-a, but had little effect on zinc-induced stimulated mononuclear cell calcitriol production. The different shape of the zinc dose response curve, and the lack of correlation between paired IL-i and calcitriol supernatant levels also suggests the effect of zinc on cellular of calcitriol by peritoneal macrophages is mediated by a nonmitochondrial hydroxylase, as is the case recently described in another extrarenal tissue [28] . The mechanism of the differential effects of FCCP on these monokines, however, remains unknown and must be addressed in further studies.
In an animal model, plasma zinc concentration in uremic subjects is dependent on nutritional zinc intake [10] . Plasma and peritoneal fluid concentrations of zinc were correlated in our patients, and were related presumably to zinc nutritional intake. Since increases in ambient zinc concentration are associated with increased cellular cytokine production and modulation of cellular immunity in patients with ESRD [11, [29] [30] [31] , and IL-i and other monokines play a key role in the early response to presented Our initial studies in an animal model suggested that the physiologic increase in calcitriol levels, in response to the stress of phosphorus or calcium depletion, was limited by nutritional zinc depletion [12, 13] . Zinc depletion is a common concomitant of renal insufficiency in patients with renal disease [7] [8] [9] and ESRD treated with CAPD [9, 20] . Mahajan et al [21] showed hypozincemia was present in patients treated with intermittent peritoneal dialysis, a finding later confirmed in patients treated with CAPD [20] . It is unclear how much of the diminution in circulating calcitriol levels in patients with ESRD treated with CAPD is a result of zinc deficiency [6, 9] . It was also uncertain whether the diminution of circulating calcitriol levels was a result of an effect on the action of hormones involved in the control of calcitriol metabolism or a direct effect of zinc on 1-a hydroxylase synthesis or activity [4, 9, 12, 13, 22] . To address such issues, we used a cellular system to assess the effect of extracellular zinc on mononuclear cell calcitriol production.
Previous studies demonstrated a zinc dependent increase in IL-1f3 and TNF-a production in human peripheral blood mononuclear cells [23, 24] . Goode et a!, however, were unable to show an increase in culture supernatant IL-1/3 levels from mononuclear cells from patients with Crohn's disease [25] . Scuderi [23] , in contrast to our findings, noted a copper dependent increase in supernatant TNF-a levels, but like Driessen et a! [24] and us, showed copper had no, or a slightly inhibitory effect on IL-1/3 release. These differences may be a consequence of the doses of zinc and copper employed in the studies, a result of the use of lipopolysaccharide instead of PHA to stimulate mononuclear cells, or a result of our use of cells from a population of patients antigens, it is reasonable to assume that zinc nutritional intake may be an important determinant of the incidence of peritonitis, infection and other immunologically related responses in patients with ESRD treated with CAPD. Calcitriol may also modulate granulocyte and immune cell function [6, 32, 33] . If local tissue and extracellular calcitriol levels are, at least in part, zinc dependent, changes in extracellular zinc levels and zinc nutritional status may therefore modulate immune function at several levels. If initial evidence suggesting calcitriol may be a factor in modulating intestinal zinc absorption in humans with ESRD is correct [reviewed in 9], zinc depletion in such patients could initiate a vicious cycle of calcitriol deficiency and subsequent immunologic impairment. We did not specifically assess the relationship of cellular cytokine metabolism to peritonitis rates in this small number of patients. Further studies to correlate nutritional status and information from zinc repletion studies with cellular responses and epidemiologic data on infection rates, and on the response to physiologic mediators of calcitriol synthesis are necessary to confirm such hypotheses. In addition, carefully conducted balance and electrolyte studies in humans are necessary to establish whether zinc nutritional status or extracellular zinc concentration play a physiologic role in the control of calcitriol metabolism in health and disease. If such a role is established, these and biochemical and molecular biologic studies will be necessary to determine the locus of interaction of zinc in the parathyroid-renal axis.
